Philips, Immunetrics Unite to Target Infectious Disease

    June 24, 2011
    Royal Philips Electronics (Netherlands) and Immunetrics Inc. (Pittsburgh) are teaming up to explore future-generation approaches to improve the
    Royal Philips Electronics (Netherlands) and Immunetrics Inc. (Pittsburgh) are teaming up to explore future-generation approaches to improve the treatment of infectious disease in critical care.

    Under the joint development agreement, Philips Research and Immunetrics will investigate the combination of advanced bioinformatics and computer modeling to identify opportunities to reduce the incidence and improve the management of systemic infection, a major complicating factor among many critically ill patients, say the companies.

    Philips currently owns a 29 percent stake in Immunetrics, a biosimulation company specializing in the computational modeling of pathophysiology and treatment.

    Continue Reading

    Sponsored Recommendations

    Streamline waste disposal, simplify compliance, and reduce unnecessary costs. This guide shows how MedPro helps practices cut confusion, not corners, while supporting over 40,...
    The patient experience doesn’t fall to just one department. Learn how your physical security system can improve safety and security, and help contribute to a positive patient ...
    Discover how identity data impacts patient safety, experience, and your system’s bottom line — and how Banner Health built a compelling case for change.
    Streamline waste disposal, simplify compliance, and reduce unnecessary costs. This guide shows how MedPro helps practices cut confusion, not corners, while supporting over 40,...